Literature DB >> 12819646

Seizures after carotid endarterectomy: hyperperfusion, dysautoregulation or hypertensive encephalopathy?

A R Naylor1, J Evans, M M Thompson, N J M London, R J Abbott, G Cherryman, P R F Bell.   

Abstract

OBJECTIVES: Presentation, management and outcome following seizure after carotid endarterectomy (CEA). MATERIALS AND
DESIGN: Prospective audit.
RESULTS: Eight patients (0.8%) suffered a seizure (three bilateral) <30 days following 949 CEAs. Seizure was not associated with age, gender or presentation. Seven were treated hypertensives but four had labile BP pre-operatively. Five had severe bilateral carotid disease and four had vertebral/subclavian stenoses. Six had a >50% drop in middle cerebral artery blood flow velocity (MCAV) with clamping. Only three had >100% increase in MCAV with flow restoration. Five required treatment for post-operative hypertension. Two suffered seizures <36 hrs of CEA, the remainder were at 3-8 days. All eight had significantly elevated blood pressure at onset of seizures. Four underwent immediate MCAV monitoring and each was elevated. Emergency CT scanning/autopsy showed normal scans (n = 3), white matter oedema (n = 3), oedema and diffuse haemorrhage (n = 1), intracranial haemorrhage (n = 1). Seven developed a post-ictal neurological deficit (stroke = 5, TIA = 2). Overall, two patients either died or suffered a disabling stroke.
CONCLUSIONS: Post-CEA seizure was associated with adverse outcome. Most were labile hypertensives with severe bilateral carotid/vertebral disease. MCAV changes suggested poor collateral recruitment, but no consistent pattern of early hyperperfusion emerged. It remains uncertain whether high MCAVs and severe hypertension after seizure onset are cause or effect. Clinicians treating these patients in acute medical units were generally unaware of the "post-CEA hyperperfusion syndrome" and tended to treat the hypertension less aggressively.

Entities:  

Mesh:

Year:  2003        PMID: 12819646     DOI: 10.1053/ejvs.2002.1925

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  8 in total

1.  Blood-brain barrier breakdown as a novel mechanism underlying cerebral hyperperfusion syndrome.

Authors:  Sebastian Ivens; Szendro Gabriel; George Greenberg; Alon Friedman; Ilan Shelef
Journal:  J Neurol       Date:  2009-11-22       Impact factor: 4.849

Review 2.  Cerebral Hyperperfusion Syndrome After Carotid Revascularization and Acute Ischemic Stroke.

Authors:  Kathryn F Kirchoff-Torres; Ekaterina Bakradze
Journal:  Curr Pain Headache Rep       Date:  2018-03-19

Review 3.  Poststroke epilepsy: epidemiology, pathophysiology and management.

Authors:  José M Ferro; Francisco Pinto
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

4.  An uncommon case of nonconvulsive status epilepticus successfully treated with enteral Brivaracetam.

Authors:  Alfredo De Liso; Lorenzo Ricci; Maria Cristina Bravi; Francesca Romana Pezzella; Sabrina Anticoli
Journal:  Acta Biomed       Date:  2021-04-30

5.  Post-carotid endarterectomy cerebral hyperperfusion syndrome.

Authors:  I K Nyamekye; S Begum; P L Slaney
Journal:  J R Soc Med       Date:  2005-10       Impact factor: 18.000

6.  Rare Complication of Carotid Stenting: New-Onset Refractory Status Epilepticus: A Study of Five Patients.

Authors:  Narayan D Deshmukh; Rakeshsingh K Singh; Rakesh S Lalla; Anil P Karapurkar; Satish V Khadilkar
Journal:  Ann Indian Acad Neurol       Date:  2019 Apr-Jun       Impact factor: 1.383

7.  Risk of Incident Epilepsy After a Middle Cerebral Artery Territory Infarction.

Authors:  Cheng-Yang Hsieh; Chien-Chou Su; Edward Chia-Cheng Lai; Yu-Shiue Chen; Tzu-Hsin Huang; Yea-Huei Kao Yang; Chih-Hung Chen; Sheng-Feng Sung; Chin-Wei Huang
Journal:  Front Neurol       Date:  2022-03-03       Impact factor: 4.003

8.  Post-carotid endarterectomy cerebral hyperperfusion syndrome : is it preventable by strict blood pressure control?

Authors:  Kyung Hyun Kim; Chang-Hyun Lee; Young-Je Son; Hee-Jin Yang; Young Sub Chung; Sang Hyung Lee
Journal:  J Korean Neurosurg Soc       Date:  2013-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.